Lack of Transparency of Clinical Trials on Endometriosis
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To estimate patterns of publication of clinical trials of endometriosis registered in ClinicalTrials.gov and their associated characteristics. METHODS: Information on interventional clinical trials on endometriosis that were registered at ClinicalTrials.gov and updated as having been completed by October 25, 2012, was retrieved and the publication status and time to publication in Medline-indexed journals were ascertained by searching PubMed and by sending e-mail inquiries to the principal investigators listed by the registry. RESULTS: Seventy-one interventional trials of endometriosis, testing various drugs and biologicals, were identified. Among them, 49.3% (35/71) were completed by October 25, 2012, 21.1% were either stopped or inactive in the past 2 years, and the remaining 29.6% were ongoing. Among the 35 completed trials, 25 (71.4%) were sponsored by industry and results were published for only 11 (31.4%; five industry-sponsored, and six nonindustry-sponsored). Trials sponsored by industry were nearly four times less likely to publish their results than nonindustry-sponsored trials, even though these trials typically had larger sample sizes and were completed faster. Compared with the publication rate of 20% found 4 years ago, the current rate has increased only marginally but still lies significantly below the reported 66.3% surveyed recently among 546 completed nonendometriosis trials registered at ClinicalTrials.gov (P<.001). CONCLUSION: Despite mounting pressure on more transparency of clinical trials, the current state of transparency or lack thereof of clinical trials on endometriosis is worrisome and does not benefit the trial sponsor or the public. Thus, we again call for more transparency for endometriosis trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejme048225 · Cited by 1,241
Simoens, S., Dunselman, G., Dirksen, C., Hummelshoj, L., Bokor, A., Brandes, I., Brodszky, V., Canis, M., Colombo, G. L., DeLeire, T., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des073 · Cited by 1,070 · cited 1×
“This revisit is justifiable on the grounds that endometriosis is a common and debilitating gynecologic condition(5) and costly to manage.(6) Despite exponential growth in endometriosis literature and many promising preclinical studies, there is a palpable disappointment over the frustratingly slow pace in drug develop…”
ResultAls-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
Ross, J. S., Mulvey, G. K., Hines, E. M., Nissen, S. E., & Krumholz, H. M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000144 · Cited by 401
Endometriosis: cost estimates and methodological perspective
Simoens, S., Hummelshoj, L., & D'Hooghe, T. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm010 · Cited by 357
Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
Bourgeois, F. T., Murthy, S., & Mandl, K. D. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00006 · Cited by 332 · cited 3×
“gov.(10) Some trials, mostly funded by industry, do not provide adequate information such as the number of target enrollment and study start and completion dates.”
BackgroundInfluentialRising, K., Bacchetti, P., & Bero, L. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050217 · Cited by 328 · cited 1×
“Despite this mounting pressure, extensive studies have found that between 22% and 47% of trials do not publish their findings at all.(2,3) Such a selective reporting poses a serious threat to professional access to all trial results and to the validity of evidence-based medicine.”
BackgroundBero, L., Oostvogel, F., Bacchetti, P., & Lee, K. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040184 · Cited by 249
Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis
Lee, K., Bacchetti, P., & Sim, I. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050191 · Cited by 215 · cited 1×
“Despite this mounting pressure, extensive studies have found that between 22% and 47% of trials do not publish their findings at all.(2,3) Such a selective reporting poses a serious threat to professional access to all trial results and to the validity of evidence-based medicine.”
Background
Research works printed but not linked: 15
- Drazen, 2005, Trial registration report card., N Engl J Med, 353, 2809, 10.1056/NEJMe058279 · DOI
- Guo, 2009, A call for more transparency of registered clinical trials on endometriosis., Hum Reprod, 24, 1247, 10.1093/humrep/dep045 · DOI · Paper page
- Burr, 1994, A comparison of certain bootstrap confidence intervals in the Cox model., J Am Stat Assoc, 89, 1290, 10.1080/01621459.1994.10476869 · DOI
- Inhaka, 1996, R: a language for data analysis and graphics., J Comput Graph Statist, 5, 1923
- Moravek, 2009, Thiazolidinediones as therapy for endometriosis: a case series., Gynecol Obstet Invest, 68, 167, 10.1159/000230713 · DOI · Paper page
- Djulbegovic, 2000, . The uncertainty principle and industry-sponsored research., Lancet, 356, 635, 10.1016/S0140-6736(00)02605-2 · DOI · Paper page
- Kjaergard, 2002, Association between competing interests and authors conclusions: epidemiological study of randomised clinical trials published in the BMJ., BMJ, 325, 249, 10.1136/bmj.325.7358.249 · DOI · Paper page
- Vedula, 2009, Outcome reporting in industry-sponsored trials of gabapentin for off-label use., N Engl J Med, 361, 1963, 10.1056/NEJMsa0906126 · DOI · Paper page
- Nkansah, 2009, Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes., Public Health Nutr, 12, 1931, 10.1017/S136898000900487X · DOI · Paper page
- Wager, 2006, Publishing clinical trial results: the future beckons., PLoS Clin Trials, 1, e31, 10.1371/journal.pctr.0010031 · DOI
- Chalmers, 1990, Underreporting research is scientific misconduct., JAMA, 263, 1405, 10.1001/jama.1990.03440100121018 · DOI · Paper page
- Jefferson, 2011, Ensuring safe and effective drugs: who can do what it takes, BMJ, 342, c7258, 10.1136/bmj.c7258 · DOI · Paper page
- Mahmood, 1991, Prevalence and genesis of endometriosis., Hum Reprod, 6, 544, 10.1093/oxfordjournals.humrep.a137377 · DOI · Paper page
- Olive, 1993, Endometriosis., N Engl J Med, 328, 1759, 10.1056/NEJM199306173282407 · DOI · Paper page
- Wood, 2009, Progress and deficiencies in the registration of clinical trials., N Engl J Med, 360, 824, 10.1056/NEJMsr0806582 · DOI · Paper page
Cited by
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
Paterni, I., Granchi, C., Katzenellenbogen, J. A., & Minutolo, F. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.012 · Cited by 721
Schmucker, C., Schell, L. K., Portalupi, S., Oeller, P., Cabrera, L., Bassler, D., Schwarzer, G., Scherer, R. W., Antes, G., von Elm, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114023 · Cited by 269
Estrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
Becker, C. M., Laufer, M. R., Stratton, P., Hummelshoj, L., Missmer, S. A., Zondervan, K. T., Adamson, G. D., Adamson, G. D., Allaire, C., Anchan, R., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.07.709 · Cited by 206
Self-citationMedical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
Guo, S.-W. (2018) · Human Reproduction · doi:10.1093/humrep/dey015 · Cited by 116
Self-citationReducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal
Vercellini, P., Giudice, L. C., Evers, J. L. H., & Abrao, M. S. (2015) · Human Reproduction · doi:10.1093/humrep/dev157 · Cited by 76
Self-citationRole of medical therapy in the management of deep rectovaginal endometriosis
Vercellini, P., Buggio, L., & Somigliana, E. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.08.038 · Cited by 62
Bashir, R., Bourgeois, F. T., & Dunn, A. G. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0518-3 · Cited by 47
Management of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
“In addition, selective reporting is another worrisome and apparently still unsolved issue in the endometriosis field.(76,77) Supposedly, patients might be more interested in knowing whether new drugs are better than OCs or safe and inexpensive progestins (e.”
BackgroundVercellini, P., Somigliana, E., Cortinovis, I., Bracco, B., de Braud, L., Dridi, D., & Milani, S. (2015) · BMC Women's Health · doi:10.1186/s12905-015-0248-4 · Cited by 22
Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science
Groothuis, P. G., & Guo, S.-W. (2018) · Reproductive Sciences · doi:10.1177/1933719118785767 · Cited by 13
Self-citationEndometriosis: the elusive gray area between evidence-based and evidence-biased medicine
Vercellini, P. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.09.023 · Cited by 7
“As Guo (2) and Guo and Evers (3) demonstrated, trial registration alone is not the solution to all problems.”
BackgroundInfluential
Metadata
- Authors
- Guo, S.-W., & Evers, J. L. H.
- Venue
- Obstetrics & Gynecology
- Published
- 2013-06
- Volume
- 121
- Issue
- 6
- Pages
- 1281-1290
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W1993456045
- Cited by
- 40
- References
- 12
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.